The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 8,826 | 1,423,578 | SH | SOLE | 1,423,578 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 2,054 | 715,754 | SH | SOLE | 715,754 | 0 | 0 | ||
| ALIMERA SCIENCES INC | COM | 016259103 | 5,731 | 6,439,498 | SH | SOLE | 6,439,498 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 18,044 | 930,604 | SH | SOLE | 930,604 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 8,387 | 2,580,518 | SH | SOLE | 2,580,518 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM | 03835L108 | 3,478 | 3,922,891 | SH | SOLE | 3,922,891 | 0 | 0 | ||
| BIODELIVERY SCIENCES INTL | COM | 09060J106 | 12,855 | 2,764,475 | SH | SOLE | 2,764,475 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 5,553 | 871,762 | SH | SOLE | 871,762 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 3,355 | 3,904,400 | SH | SOLE | 3,904,400 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 5,526 | 65,484 | SH | SOLE | 65,484 | 0 | 0 | ||
| FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 1,550 | 651,211 | SH | SOLE | 651,211 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 4,624 | 2,785,585 | SH | SOLE | 2,785,585 | 0 | 0 | ||
| INTERPACE DIAGNOSTICS GROUP | COM NEW | 46062X204 | 1,271 | 1,753,184 | SH | SOLE | 1,753,184 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 5,348 | 4,113,522 | SH | SOLE | 4,113,522 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 19,119 | 167,487 | SH | SOLE | 167,487 | 0 | 0 | ||
| MOTUS GI HOLDINGS INC | COM | 62014P108 | 107 | 35,205 | SH | SOLE | 35,205 | 0 | 0 | ||
| MATINAS BIOPHARMA HOLDINGS I | COM | 576810105 | 573 | 668,615 | SH | SOLE | 668,615 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM | 64052L106 | 6,413 | 4,971,014 | SH | SOLE | 4,971,014 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 383 | 491,096 | SH | SOLE | 491,096 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 4,180 | 315,468 | SH | SOLE | 315,468 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 3,136 | 227,900 | SH | SOLE | 227,900 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 508 | 162,244 | SH | SOLE | 162,244 | 0 | 0 | ||
| VIVEVE MEDICAL INC | COM NEW | 92852W204 | 1,293 | 3,403,402 | SH | SOLE | 3,403,402 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 18,908 | 1,341,943 | SH | SOLE | 1,341,943 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 4,019 | 270,449 | SH | SOLE | 270,449 | 0 | 0 | ||